Enhancing Cancer Vaccine Science for New Therapy Pathways

The main objective of the project Enhancing Cancer Vaccine Science for New Therapy Pathways (CANVAS) is to significantly raise the scientific profile, networking, and research management competencies at the International Centre for Cancer Vaccine Science (ICCVS) at the University of Gdask (UG), Poland, to achieve improved research excellence in cancer vaccine science.

The project aims to contribute to reduction of the disparities in R&I in Europe by networking activities with outstanding leading European research partners: University of Rome Tor Vergata (UNITOV), Italy, and Alternative Energies and Atomic Energy Commission (CEA), France.

The partnership includes also a biotech start-up Real Research (Poland), to foster intersectoral knowledge transfer for innovative translational research approaches.

A strong focus on upgrade of grant writing and research management skills will improve long-term competitiveness in obtaining funding. In addition a joint pilot study is planned in the project. We expect that it will provide the foundation for a novel patient tailored therapy of non-small cell lung cancer.

Thus, apart from the scientific impact, in the long term innovations generated with the support of the CANVAS partnership have a translational potential to contribute to improving therapy for cancer patients, which give the project a pivotal economic and societal impact.